Angiographic trials of lipid-lowering therapy: end of an era?
Open Access
- 1 October 1995
- Vol. 74 (4) , 343-347
- https://doi.org/10.1136/hrt.74.4.343
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)The Lancet, 1994
- Association between lipoprotein(a) and progression of coronary artery disease in middle-aged menThe American Journal of Cardiology, 1994
- Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterolJournal of the American College of Cardiology, 1994
- Atherosclerosis Regression, Plaque Disruption, and Cardiovascular Events: A Rationale for Lipid Lowering in Coronary Artery DiseaseAnnual Review of Medicine, 1993
- Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)The Lancet, 1992
- Atherosclerosis: inhibition of regression as therapeutic possibilities.Heart, 1991
- Can lifestyle changes reverse coronary heart disease?: The Lifestyle Heart TrialPublished by Elsevier ,1990
- INTERMEDIATE-DENSITY LIPOPROTEINS AND PROGRESSION OF CORONARY ARTERY DISEASE IN HYPERCHOLESTEROLAEMIC MENThe Lancet, 1987
- The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulation, 1984